Global Insulin Pump Market - Focused Insights 2021-2030

THE GLOBAL INSULIN PUMP MARKET WAS VALUED AT USD 4.31 BILLION IN 2024 AND IS EXPECTED TO REACH USD 7.27 BILLION BY 2030, GROWING AT A CAGR OF 9.10% DURING THE FORECAST PERIOD.

 Insulin Pump Market Report

The Insulin Pump Market Size, Share & Trend Analysis by Product Type, by Indication Type, by End-User & Geographical Analysis, Growth, Insights, Forecast 2021-2030

151 pages

53 tables

40 charts

5 region

21 countries

23 company

05 segments

Purchase Options

$3500
$3650
$4999
$2000

Global Insulin Pump Market - Focused Insights 2021-2030

THE GLOBAL INSULIN PUMP MARKET WAS VALUED AT USD 4.31 BILLION IN 2024 AND IS EXPECTED TO REACH USD 7.27 BILLION BY 2030, GROWING AT A CAGR OF 9.10% DURING THE FORECAST PERIOD.

The Insulin Pump Market Size, Share & Trend Analysis Report By

  1. Product Type: Insulin Pump and Consumables
  2. Insulin Pump: Tethered Pump and Patch Pump
  3. Indication Type: Type 1 Diabetes and Type 2 Diabetes
  4. End-Users: Hospitals, Home Healthcare Settings, and Others
  5. Geography: North America, Europe, APAC, Middle East & Africa, and Latin America

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2025–2030.

Customize this Report

This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize

GLOBAL INSULIN PUMP MARKET REPORT SCOPE

REPORT ATTRIBUTEDETAILS
Market Size (2030)USD 7.27 Billion
Market Size (2024)USD 4.31 Billion
CAGR (2024-2030)9.10%
HISTORIC YEAR2021-2023
BASE YEAR2024
FORECAST YEAR2025-2030
LARGEST REGION (2024)North America
FASTEST-GROWING REGIONAsia Pacific
SEGMENTS BYProduct Type, Insulin Pump, Indication Type, End-Users, and Geography
GEOGRAPHIC ANALYSISNorth America, Europe, APAC, Latin America, and the Middle East & Africa
KEY PLAYERSInsulet, Medtronic, and Tandem Diabetes Care
Interested in this Report?

INSULIN PUMP MARKET SIZE

The global insulin pump market was valued at USD 4.31 billion in 2024 and is expected to reach USD 7.27 billion by 2030, growing at a CAGR of 9.10% during the forecast period. The market is experiencing significant growth, driven by the increasing prevalence of diabetes, technological advancements, and a growing demand for precise and convenient diabetes management solutions. Additionally, this growth is attributed to factors such as the rising incidence of diabetes, particularly type 1 diabetes, and the increasing adoption of advanced insulin delivery technologies.

Increasing diabetes prevalence is the major factor driving the adoption and demand for insulin pumps. Globally, more than 589 million adults between the age groups 20 to 79 are living with diabetes. It accounted for 1 in 10 people who have diabetes. According to the International Diabetes Federation (IDF), the estimated diabetes patient population will be 853 million by 2050. Around 3 in 4 adult diabetes patients are living in low- and middle-income countries. It is one of the leading public health concerns in every country, which is responsible for around 6.7 million deaths in 2021 (1 death in every 5 seconds).

Technological innovations have been pivotal in propelling the insulin pump market forward. Modern insulin pumps are increasingly integrated with continuous glucose monitoring (CGM) systems, enabling real-time glucose tracking and automated insulin delivery adjustments. The development of closed-loop systems, often referred to as artificial pancreas systems, exemplifies this advancement, offering improved glycemic control and reduced risk of hypoglycemia.

An insulin pump is a small, computerized medical device used by people with diabetes to continuously deliver insulin into their bodies. It mimics the way a healthy pancreas delivers insulin, helping to maintain stable blood glucose (sugar) levels. Insulin pumps are used primarily by people with type 1 diabetes and in some cases by those with type 2 diabetes who require intensive insulin therapy. They offer an alternative to multiple daily insulin injections and can lead to better blood sugar control, fewer highs and lows, and improved quality of life.

KEY TAKEAWAYS

  1. Market Growth: The global insulin pump market size was valued at USD 4.31 billion in 2024 and is expected to reach USD 7.27 billion by 2030, growing at a CAGR of 9.10%.
  2. By Product Type: In 2024, the insulin pump segment accounted for over 65% of the global market share, making it the largest category within the global insulin pump market.
  3. By Indication Type: The type 1 segment is expected to grow at the fastest CAGR of 9.31%, contributing significantly to the overall expansion of the market.
  4. By End-User: The hospital segment accounted for the largest market share.
  5. By Geography: North America holds the largest market share of over 38%, and APAC shows the highest growth during the forecast period.
  6. Growth Factor: The global insulin pump market is set to grow due to the growing prevalence of diabetes and technological advancements in insulin pump design.

INSULIN PUMP MARKET TRENDS & DRIVERS

Increase in Number of Product Approvals

The insulin pump industry is witnessing a surge in product approvals, reflecting intensified research and development efforts aimed at enhancing diabetes management. Notable recent approvals include:

  1. Medtronic MiniMed 780G: Approved in 2023, this advanced automated insulin delivery system features 'Meal Detection Technology' and integrates with continuous glucose monitoring (CGM) to automatically adjust insulin delivery, improving glycemic control for users aged 7 and older with type 1 diabetes.
  2. Tandem Mobi: Launched in 2024, Tandem Diabetes Care introduced this compact automated insulin delivery system in the US, offering users more choices and innovative options for wearability.

These approvals signify a commitment to expanding treatment options and improving the quality of life for individuals managing diabetes.

Rising Adoption of Automated Insulin Delivery (AID) Systems

Automated Insulin Delivery systems, also known as artificial pancreas systems, are gaining traction due to their ability to automate insulin dosing based on real-time glucose readings. Omnipod 5 system integrates with leading CGM sensors, providing automated insulin delivery without the need for manual adjustments, enhancing glycemic control and reducing the burden of diabetes management. The adoption of AID systems is transforming diabetes care by offering more precise and user-friendly insulin delivery methods.

Growing Prevalence of Diabetes

The rising global incidence of diabetes, especially Type 1 diabetes, is one of the most significant factors driving the insulin pump market. According to the International Diabetes Federation (IDF), over 589 million adults worldwide were living with diabetes in 2024, a number projected to reach 853 million by 2050. As diabetes becomes more widespread across age groups and regions, there is a growing demand for effective and manageable insulin delivery methods. Insulin pumps provide more precise glucose control than traditional methods, making them increasingly attractive to healthcare providers and patients alike.

Technological Advancements

Advances in diabetes technology have significantly enhanced the capabilities and appeal of insulin pumps. Innovations include:

  1. Integration with Continuous Glucose Monitoring (CGM) systems
  2. Automated insulin delivery (closed-loop or artificial pancreas systems)
  3. Bluetooth-enabled smart pumps with mobile app connectivity
  4. Use of AI and machine learning for predictive insulin dosing

These advancements have improved patient outcomes, reduced management burdens, and increased trust in pump technology. Moreover, user-friendly interfaces, discreet designs, and better battery life contribute to higher adoption rates.

INSULIN PUMPS MARKET SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT TYPE

The global insulin pump market by product type is segmented into insulin pumps and consumables. In 2024, the insulin pump segment accounted for over 65% of the market share. The insulin pump is a portable medical device that is attached to the body and continuously delivers the amount of rapid or short-acting insulin through a catheter that is placed under the skin. Insulin pumps are available in two forms such as tethered and patch pumps. With the increasing diabetes prevalence posing a significant burden on health systems, a demand for new technologies in diabetes care delivery. The advancement in insulin pumps stands as a golden opportunity for diabetes patients as well as healthcare professionals.

The tethered pumps maintain a large user base due to their precision and customizability. Tethered pumps serve key advantages like high customization, precision in dosing, integration with CGMs, and proven reliability. While patch pumps are rapidly growing with their user-friendly design. The future of patch insulin pumps looks favorable, driven by advancements in wearable technology, AI integration, and growing consumer demand for convenience.

INSIGHTS BY INDICATION TYPE

The global insulin pump market by indication type is categorized into type 1 diabetes and type 2 diabetes. Type 1 diabetes shows significant growth, with the fastest-growing CAGR of 9.31% during the forecast period. It is one of the leading chronic conditions that severely impacts all demographics. Insulin pumps offer an advanced alternative by delivering continuous subcutaneous insulin infusion (CSII), mimicking the body's natural insulin patterns. This is particularly beneficial for T1D patients who need both basal (background) and bolus (mealtime) insulin throughout the day.

The combination of insulin pumps with continuous glucose monitors (CGMs) and advanced algorithms has led to automated insulin delivery systems (also known as hybrid closed-loop or artificial pancreas systems), which are especially beneficial for Type 1 diabetes patients. Insulin pumps are widely recommended for children and adolescents with Type 1 diabetes, as they offer better control with less discomfort than multiple daily injections.

INSIGHTS BY END-USER

Based on the end-user, the hospital segment accounted for the largest global insulin pump market share. Hospitals are the primary care settings that are operating the major diabetes burden every day. The significant patient population is dependent on the hospital setting to manage their diabetes. As the prevalence of diabetes increases every day, the demand and popularity of diabetes management devices are increasing, with insulin pumps becoming a top priority for medical professionals.

Hospitals often serve as the starting point for new insulin pump users, providing the necessary medical evaluation, device setup, and training by endocrinologists and diabetes educators. Hospitals are a key institutional customer segment for insulin pump manufacturers. Hospitals often purchase pumps for use in diabetes education clinics and training sessions. Many hospitals conduct research involving insulin pumps to evaluate new technologies and treatment protocols, helping to expand the evidence base.

GEOGRAPHICAL ANALYSIS

North America dominates and holds the largest global insulin pump market share of over 38%. North America stands as the dominant region in the global insulin pump market, driven by advanced healthcare infrastructure, high diabetes prevalence, and widespread adoption of medical technologies. The US and Canada have been at the forefront of insulin pump innovation, usage, and regulatory advancements. North America, particularly the US, stands as the most mature market for insulin pumps. The region benefits from a well-established healthcare system, high diabetes prevalence, robust insurance coverage, and the presence of leading insulin pump manufacturers such as Medtronic and Tandem Diabetes Care. In addition, the presence of market players and greater access to the insulin pump solution with higher economic stability give a boost to the market growth. Medtronic, Insulet, and Tandem Diabetes Care are the three major companies which has significant market penetration in the region.

The APAC region is expected to grow at the fastest CAGR of 10.84% during the forecast period. The APAC region presents a significant burden of diabetes. According to the IDF, countries like China and India have some of the highest numbers of people living with diabetes globally. Rising urbanization, sedentary lifestyles, and dietary changes have contributed to a surge in both Type 1 and Type 2 diabetes, particularly in urban and middle-income populations. The regulatory landscape in APAC is evolving, with a growing emphasis on patient safety and medical device efficacy. Countries such as Japan, South Korea, and Australia have well-established regulatory bodies that closely evaluate insulin pump products before approval.

INSULIN PUMP MARKET VENDOR LANDSCAPE

The global insulin pump market report contains exclusive data on 23 vendors. The market is a dynamic and competitive space driven by rapid technological advancements, increasing diabetes prevalence, and a growing shift toward patient-centric care. The market is characterized by a mix of established industry leaders, innovative startups, and strategic collaborations aiming to offer smarter, safer, and more efficient insulin delivery solutions. The insulin pump landscape is primarily dominated by a few major players with global reach, including Medtronic, Insulet, and Tandem Diabetes Care. Other notable players include Roche, Ypsomed, SOOIL Development, Debiotech, and emerging firms such as Beta Bionics and Modular Medical, which are introducing next-gen technologies. Companies are investing heavily in R&D to develop smaller, smarter, and interoperable pumps with features like touchscreen displays, Bluetooth connectivity, and closed-loop automation.

RECENT VENDORS ACTIVITIES

Vendors are heavily investing in R&D to develop next-generation insulin pumps that offer better control, ease of use, and integration with other diabetes management technologies.

  1. Medtronic: Medtronic continues to enhance its MiniMed series, including the 780G system, a hybrid closed-loop pump that automatically adjusts insulin delivery based on CGM (Continuous Glucose Monitoring) readings.
  2. Insulet Corporation: Known for its Omnipod tubeless, patch-style pump, Insulet focuses on discreet, wearable insulin delivery. Its newer models, like the Omnipod 5, feature automated insulin dosing with real-time glucose data.
  3. Tandem Diabetes Care: Offers t:slim X2 insulin pump with Control-IQ technology, integrating CGM and automated insulin delivery. The company is known for its user-friendly touchscreen interface and software update capability.
  4. Many vendors are focusing on building ecosystems that combine insulin pumps with mobile apps, AI algorithms, and CGM devices to create a seamless user experience.
  5. Partnerships with CGM companies like Dexcom and Abbott have become standard, allowing pumps to make real-time insulin adjustments based on glucose levels.
  6. Vendors are also exploring cloud-based platforms for remote monitoring and telehealth compatibility, allowing healthcare providers to track patient data more efficiently.

SNAPSHOT

The global insulin pump market size is expected to grow at a CAGR of approximately 9.10% from 2024 to 2030.

Base Year: 2024

Forecast Year: 2025-2030

The report considers the present scenario of the global insulin pump and its market dynamics for 2025−2030. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.

Key Vendors

  1. Insulet
  2. Business Overview
  3. Product Offerings
  4. Key Developments
  5. Key Strategies
  6. Key Opportunities
  7. Key Strengths
  8. Medtronic
  9. Tandem Diabetes Care

Other Prominent Vendors

  1. CeQur Simplicity
  2. Business Overview
  3. Product Offerings
  4. Debiotech SA
  5. EOFLOW
  6. F. Hoffmann-La Roche
  7. IA Collaborative Holdings
  8. Jiangsu Delfu medical device
  9. LenoMed Medical
  10. MannKind
  11. Medtrum Technologies
  12. Medzer
  13. MicroPort Scientific
  14. MicroTech Medical
  15. Novo Nordisk
  16. Shanghai Umitai Medical Technology 
  17. SOOIL Developments
  18. Terumo
  19. ViCentra B.V. 
  20. YPSOMED AG
  21. Modular Medical
  22. Beta Bionics

SEGMENTATION & FORECASTS

  1. By Product Type
  2. Insulin Pump
  3. Consumables
  4. By Insulin Pump
  5. Tethered Pump
  6. Patch Pump
  7. By Indication Type
  8. Type 1 Diabetes
  9. Type 2 Diabetes
  10. By End-Users
  11. Hospitals
  12. Home Healthcare Settings
  13. Others
  14. By Geography
  15. North America
  16. US
  17. Canada
  18. Europe
  19. Germany
  20. France
  21. UK
  22. Italy
  23. Spain
  24. Russia
  25. Netherlands
  26. APAC
  27. China
  28. Japan
  29. India
  30. South Korea
  31. Australia
  32. Latin America
  33. Brazil
  34. Mexico
  35. Argentina
  36. Columbia
  37. Middle East & Africa
  38. Turkey
  39. Saudi Arabia
  40. South Africa

GLOBAL INSULIN PUMP MARKET FAQs

How big is the global insulin pump market?

The global insulin pump market size was valued at USD 4.31 billion in 2024 and is expected to reach USD 7.27 billion by 2030.

How are technological advancements impacting the market?

Technologies such as smartphone integration, Bluetooth connectivity, AI-powered insulin dosing, and cloud-based remote monitoring are making insulin pumps more accurate, user-friendly, and accessible.

What is the growth rate of the global insulin pump market?

The global insulin pump market is expected to grow at a CAGR of 9.10% during the forecast period.

What is driving the growth of the global insulin pump market?

The rising global prevalence of diabetes, especially type 1 diabetes, and an increasing transition from multiple daily injections (MDI) to pump therapy are key driving factors of the global insulin pump market.

Are insulin pumps used for both Type 1 and Type 2 diabetes?

Primarily used for Type 1 diabetes, insulin pumps are increasingly being adopted for Type 2 diabetes patients who require intensive insulin therapy and have difficulty controlling blood sugar with injections.

Who are the key players in the global insulin pump market?

Insulet, Medtronic, and Tandem Diabetes Care are the key players in the global insulin pump market.

EXHIBIT 1         Global Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 2         Global Insulin Pump Market by Product Type 2021-2030 ($ billion)

EXHIBIT 3         Market by Insulin Pump 2021-2030 ($ billion)

EXHIBIT 4         Market by Tethered Pump 2021-2030 ($ billion)

EXHIBIT 5         Market by Patch Insulin Pump 2021-2030 ($ billion)

EXHIBIT 6         Market by Consumables 2021-2030 ($ billion)

EXHIBIT 7         Global Insulin Pump Market by Indication Type 2021-2030 ($ billion)

EXHIBIT 8         Market by Type 1 Diabetes 2021-2030 ($ billion)

EXHIBIT 9         Market by Type 2 Diabetes 2021-2030 ($ billion)

EXHIBIT 10      Global Insulin Pump Market by End-user 2021-2030 ($ billion)

EXHIBIT 11      Market by Hospitals 2021-2030 ($ billion)

EXHIBIT 12      Market by Home Healthcare Settings 2021-2030 ($ billion)

EXHIBIT 13      Market by Others 2021-2030 ($ billion)

EXHIBIT 14      Global Insulin Pump Market by Geography 2021-2030 ($ billion)

EXHIBIT 15      North America Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 16      US Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 17      Canada Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 18      Europe Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 19      Germany Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 20      France Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 21      UK Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 22      Italy Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 23      Spain Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 24      Russia Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 25      Netherlands Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 26      APAC Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 27      China Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 28      Japan Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 29      India Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 30      South Korea Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 31      Australia Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 32      Latin America Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 33      Brazil Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 34      Mexico Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 35      Argentina Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 36      Colombia Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 37      Middle East & Africa Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 38      Turkey Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 39      Saudi Arabia Insulin Pump Market 2021-2030 ($ billion)

EXHIBIT 40      South Africa Insulin Pump Market 2021-2030 ($ billion)


LIST OF TABLES

TABLE 1          Global Insulin Pump Market by Geography 2021-2023 ($ billion)

TABLE 2            Global Insulin Pump Market by Geography 2024-2030 ($ billion)    

TABLE 3           Global Insulin Pump Market by Product Type 2021-2023 ($ billion)

TABLE 4         Global Insulin Pump Market by Product Type 2024-2030 ($ billion)

TABLE 5            Global Insulin Pump Market by Geography 2021-2023 ($ billion)

TABLE 6           Global Insulin Pump Market by Geography 2024-2030 ($ billion)

TABLE 7           Global Tethered Insulin Pump Market by Geography 2021-2023 ($ billion)

TABLE 8           Global Tethered Insulin Pump Market by Geography 2024-2030 ($ billion)

TABLE 9          Global Patch Insulin Pump Market by Geography 2021-2023 ($ billion)

TABLE 10         Global Patch Insulin Pump Market by Geography 2024-2030 ($ billion)

TABLE 11         Global Consumables Insulin Pump Market by Geography 2021-2023 ($ billion)

TABLE 12         Global Consumables Insulin Pump Market by Geography 2024-2030 ($ billion)

TABLE 13         Global Insulin Pump Market by Indication Type 2021-2023 ($ billion)

TABLE 14          Global Insulin Pump Market by Indication Type 2024-2030 ($ billion)

TABLE 15         Global Type 1 Diabetes Insulin Pump Market by Geography 2021-2023 ($ billion)

TABLE 16         Global Type 1 Diabetes Insulin Pump Market by Geography 2024-2030 ($ billion)

TABLE 17         Global Type 2 Diabetes Insulin Pump Market by Geography 2021-2023 ($ billion)

TABLE 18         Global Type 2 Diabetes Insulin Pump Market by Geography 2024-2030 ($ billion)

TABLE 19          Global Insulin Pump Market by End-user 2021-2023 ($ billion)

TABLE 20          Global Insulin Pump Market by End-user 2024-2030 ($ billion)

TABLE 21         Global Hospitals Insulin Pump Market by Geography 2021-2023 ($ billion)

TABLE 22         Global Home Healthcare Settings Diabetes Insulin Pump Market by Geography 2024-2030 ($ billion)

TABLE 23         Global Others Insulin Pump Market by Geography 2021-2023 ($ billion)

TABLE 24         North America Insulin Pump Market by Product Type 2021-2023 ($ billion)

TABLE 25         North America Insulin Pump Market by Product Type 2024-2030 ($ billion)

TABLE 26         North America Insulin Pump Market by Indication Type 2021-2023 ($ billion)

TABLE 27         North America Insulin Pump Market by Indication Type 2024-2030 ($ billion)

TABLE 28         North America Insulin Pump Market by End-user 2021-2023 ($ billion)

TABLE 29         North America Insulin Pump Market by End-user 2024-2030 ($ billion)

TABLE 30         Europe Insulin Pump Market by Product Type 2021-2023 ($ billion)

TABLE 31         Europe Insulin Pump Market by Product Type 2024-2030 ($ billion)

TABLE 32         Europe Insulin Pump Market by Indication Type 2021-2023 ($ billion)

TABLE 33         Europe Insulin Pump Market by Indication Type 2024-2030 ($ billion)

TABLE 34         Europe Insulin Pump Market by End-user 2021-2023 ($ billion)

TABLE 35         Europe Insulin Pump Market by End-user 2024-2030 ($ billion)

TABLE 36         APAC Insulin Pump Market by Product Type 2021-2023 ($ billion)

TABLE 37         APAC Insulin Pump Market by Product Type 2024-2030 ($ billion)

TABLE 38         APAC Insulin Pump Market by Indication Type 2021-2023 ($ billion)

TABLE 39         APAC Insulin Pump Market by Indication Type 2024-2030 ($ billion)

TABLE 40         APAC Insulin Pump Market by End-user 2021-2023 ($ billion)

TABLE 41         APAC Insulin Pump Market by End-user 2024-2030 ($ billion)

TABLE 42         Latin America Insulin Pump Market by Product Type 2021-2023 ($ billion)

TABLE 43         Latin America Insulin Pump Market by Product Type 2024-2030 ($ billion)

TABLE 44         Latin America Insulin Pump Market by Indication Type 2021-2023 ($ billion)

TABLE 45         Latin America Insulin Pump Market by Indication Type 2024-2030 ($ billion)

TABLE 46         Latin America Insulin Pump Market by End-user 2021-2023 ($ billion)

TABLE 47         Latin America Insulin Pump Market by End-user 2024-2030 ($ billion)

TABLE 48         Middle East & Africa Insulin Pump Market by Product Type 2021-2023 ($ billion)

TABLE 49         Middle East & Africa Insulin Pump Market by Product Type 2024-2030 ($ billion)

TABLE 50         Middle East & Africa Insulin Pump Market by Indication Type 2021-2023 ($ billion)

TABLE 51         Middle East & Africa Insulin Pump Market by Indication Type 2024-2030 ($ billion)

TABLE 52         Middle East & Africa Insulin Pump Market by End-user 2021-2023 ($ billion)

TABLE 53         Middle East & Africa Insulin Pump Market by End-user 2024-2030 ($ billion)

CHAPTER – 1: Scope & Coverage: Insulin Pump Market Overview

  1. Market Derivation
  2. Market Definition
  3. Segment Coverage & Definition


CHAPTER – 2: Insulin Pump Market Prospects & Opportunities

  1. Insulin Pump Market Introduction
  2. Insulin Pump Market Opportunities & Trends
  3. Insulin Pump Market Enablers
  4. Insulin Pump Market Restraints


CHAPTER – 3: Insulin Pump Market Landscape

  1. GLOBAL: Market Revenue of Insulin Pump Market (2021-2030; $ billions)


CHAPTER – 4: Insulin Pump Market Segmentation Data

  1. GLOBAL: Market Revenue by Product Type (2021-2030; $ Billions) 
  2. Pump
  3. Consumables
  4. GLOBAL: Market Revenue by Indication Type (2021-2030; $ Billions) 
  5. Type 1 Diabetes
  6. Type 2 Diabetes
  7. GLOBAL: Market Revenue by End-users (2021-2030; $ Billions) 
  8. Hospitals
  9. Home Healthcare Settings
  10. Others


CHAPTER – 5: Key Regions Overview

  1. North America: Market Revenue & Forecast (2021-2030; $ Billions) 
  2. Market Revenue & Forecast of Insulin Pump Market in the US
  3. Market Revenue & Forecast of Insulin Pump Market in Canada


  1. Europe: Market Revenue & Forecast (2021-2030; $ Billions) 
  2. Market Revenue & Forecast of Insulin Pump Market in Germany
  3. Market Revenue & Forecast of Insulin Pump Market in France
  4. Market Revenue & Forecast of Insulin Pump Market in the UK
  5. Market Revenue & Forecast of Insulin Pump Market in Italy
  6. Market Revenue & Forecast of Insulin Pump Market in Spain
  7. Market Revenue & Forecast of Insulin Pump Market in Russia
  8. Market Revenue & Forecast of Insulin Pump Market in the Netherlands


  1. APAC: Market Revenue & Forecast (2021-2030; $ Billions) 
  2. Market Revenue & Forecast of Insulin Pump Market in China
  3. Market Revenue & Forecast of Insulin Pump Market in Japan
  4. Market Revenue & Forecast of Insulin Pump Market in India
  5. Market Revenue & Forecast of Insulin Pump Market in South Korea
  6. Market Revenue & Forecast of Insulin Pump Market in Australia


  1. Latin America: Market Revenue & Forecast (2021-2030; $ Billions) 
  2. Market Revenue & Forecast of Insulin Pump Market in Brazil
  3. Market Revenue & Forecast of Insulin Pump Market in Mexico
  4. Market Revenue & Forecast of Insulin Pump Market in Argentina
  5. Market Revenue & Forecast of Insulin Pump Market in Colombia


  1. Middle East & Africa: Market Revenue & Forecast (2021-2030; $ Billions) 
  2. Market Revenue & Forecast of Insulin Pump Market in Turkey
  3. Market Revenue & Forecast of Insulin Pump Market in Saudi Arabia
  4. Market Revenue & Forecast of Insulin Pump Market in South Africa


CHAPTER – 6: Competitive Landscape of Insulin Pump Market

  1. Insulin Pump Market - Competitive Landscape
  2. Insulin Pump Market– Key Vendor Profiles
  3. Insulin Pump Market– Other Prominent Vendors
  4. Insulin Pump Market - Key Strategic Recommendations


CHAPTER – 7: Appendix

  1. Research Methodology
  2. Abbreviations
  3. About Arizton

Select a license type that suits your business needs

Single User Licence

$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email

5 User Licence

$3650.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Corporate Licence

$4999.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Datasheet Licence

$2000.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Frequently Asked Questions

How big is the global insulin pump market?

The global insulin pump market size was valued at USD 4.31 billion in 2024 and is expected to reach USD 7.27 billion by 2030.

How are technological advancements impacting the market?

Technologies such as smartphone integration, Bluetooth connectivity, AI-powered insulin dosing, and cloud-based remote monitoring are making insulin pumps more accurate, user-friendly, and accessible.

What is the growth rate of the global insulin pump market?

The global insulin pump market is expected to grow at a CAGR of 9.10% during the forecast period.

What is driving the growth of the global insulin pump market?

The rising global prevalence of diabetes, especially type 1 diabetes, and an increasing transition from multiple daily injections (MDI) to pump therapy are key driving factors of the global insulin pump market.

Are insulin pumps used for both Type 1 and Type 2 diabetes?

Primarily used for Type 1 diabetes, insulin pumps are increasingly being adopted for Type 2 diabetes patients who require intensive insulin therapy and have difficulty controlling blood sugar with injections.

Who are the key players in the global insulin pump market?

Insulet, Medtronic, and Tandem Diabetes Care are the key players in the global insulin pump market.